REST Study: Left Ventricular Regression European Study
This study has been completed.
Sponsor:
St. Jude Medical
Information provided by:
St. Jude Medical
ClinicalTrials.gov Identifier:
NCT00256165
First received: November 16, 2005
Last updated: March 30, 2009
Last verified: March 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to obtain data regarding the left ventricular mass (LVM) regression 6 months after the implant of an SJM Epic™ and SJM Epic™ Supra valve by comparing LVM regression measured with magnetic resonance imaging (MRI) to LVM regression measured with echocardiography (2-dimensional [2D] mandatory; 3-dimensional [3D] in sites where the technology is available).
| Condition | Intervention | Phase |
|---|---|---|
|
Aortic Valve Stenosis |
Device: Tissue valve |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Diagnostic |
| Official Title: | Left Ventricular Regression European Study |
Resource links provided by NLM:
Further study details as provided by St. Jude Medical:
Primary Outcome Measures:
- The comparison of left ventricular mass index (LVMI) at 6 months between echocardiogram (echo) and MRI in patients implanted with an Epic valve [ Time Frame: At 6 months ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 150 |
| Study Start Date: | January 2006 |
| Study Completion Date: | July 2008 |
| Primary Completion Date: | July 2008 (Final data collection date for primary outcome measure) |
Intervention Details:
-
Device: Tissue valve
Aortic valve replacement
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Patient requires, for the first time, isolated aortic valve replacement due to aortic stenosis or mixed aortic stenosis disease etiology when aortic stenosis is predominant and aortic regurgitation is mild.
- Patient is of legal age in the host country.
- Patient (or legal guardian) has signed a study specific informed consent form
Exclusion Criteria:
- Patient was previously operated on with any heart surgery including heart valve replacement or coronary artery bypass graft (CABG); or underwent any form of myocardial revascularization in the past (including stents), etc.
- Patient requires any concomitant heart surgery other than the isolated native aortic heart valve replacement and concomitant ascending aortic replacement (e.g not allowed are: multiple valve replacements or concomitant CABG, pacemaker insertions, or severe septal hypertrophy needing surgical excision, etc.)
- Patient has unstable angina
- Patient is in New York Heart Association functional class IV
- Patient has significant abnormality in wall motion
- Patient is affected by active endocarditis.
- Patient has a cardiac pacemaker or automatic implanted cardiac defibrillator
- Patient is affected by acute aortic dissection.
- Patient is in chronic and persistent atrial fibrillation
- Patient receives hemodialysis therapy
- Patient has a medical condition which contraindicates implantation of the SJM Epic and Epic™ Supra Porcine Bioprosthetic Heart Valve (e.g. renal failure or abnormal calcium metabolism).
- Patient has aneurysmal clips or carotid artery vascular stents
- Patient has a neurostimulator
- Patient has an implanted or external drug infusion device (e.g. insulin pump)
- Patient has a bone growth/fusion stimulator
- Patient has a cochlear, otologic, or ear implant
- Patients with severe claustrophobia in which medical sedation is contraindicated or unable to resolve anxiety sufficiently
- Patients with ocular foreign body (e.g. metal shavings)
- Patient is pregnant or nursing
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00256165
Locations
| Germany | |
| Städtlishes Klinikum Braunschweig | |
| Braunschweig, Germany, 38126 | |
Sponsors and Collaborators
St. Jude Medical
Investigators
| Principal Investigator: | G. Gerosa, Prof. | Policlinico Universitario Cardiovasculare - Padua - Italy |
More Information
No publications provided by St. Jude Medical
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Christophe Bailleul, St. Jude Medical |
| ClinicalTrials.gov Identifier: | NCT00256165 History of Changes |
| Other Study ID Numbers: | CS04009TV |
| Study First Received: | November 16, 2005 |
| Last Updated: | March 30, 2009 |
| Health Authority: | Germany: Federal Institute for Drugs and Medical Devices France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis) |
Keywords provided by St. Jude Medical:
|
Aortic valve replacement |
Additional relevant MeSH terms:
|
Aortic Valve Stenosis Heart Valve Diseases Heart Diseases Cardiovascular Diseases Ventricular Outflow Obstruction |
ClinicalTrials.gov processed this record on May 23, 2013